SPLICE BIO
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
SPLICE BIO
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2012-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.splice.bio
Total Employee:
11+
Status:
Active
Contact:
+34934020456
Email Addresses:
[email protected]
Total Funding:
51.7 M EUR
Technology used in webpage:
SPF Google Maps Microsoft Exchange Online Office 365 Mail Google Maps API Microsoft Azure DNS GoDaddy DNS
Similar Organizations
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Splice Bio
Gilde Healthcare
Gilde Healthcare investment in Series A - Splice Bio
UCB Ventures
UCB Ventures investment in Series A - Splice Bio
Asabys Partners
Asabys Partners investment in Series A - Splice Bio
Ysios Capital
Ysios Capital investment in Series A - Splice Bio
New Enterprise Associates
New Enterprise Associates investment in Series A - Splice Bio
Asabys Partners
Asabys Partners investment in Venture Round - Splice Bio
Ysios Capital
Ysios Capital investment in Venture Round - Splice Bio
Criteria Venture Tech
Criteria Venture Tech investment in Series A - Splice Bio
Key Employee Changes
Official Site Inspections
http://www.splice.bio Semrush global rank: 8.49 M Semrush visits lastest month: 523
- Host name: cl2024092609001.dnssw.net
- IP address: 81.25.126.103
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Splice Bio"
Home - Splice Bio
SpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to develop the next generation of gene therapies. Our platform is based on technology …See details»
SpliceBio 2025 Company Profile: Valuation, Funding
Dec 2, 2017 Information on valuation, funding, cap tables, investors, and …See details»
SpliceBio - LinkedIn
SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on …See details»
Splice Bio - Crunchbase Company Profile & Funding
Splice Bio develops gene therapies using its Protein Splicing platform for …See details»
Splice Bio: Revenue, Worth, Valuation & Competitors 2025
Splice Bio has an estimated revenue of $9.1M, and 50+ employees. Alternatives of Splice Bio are Dermavant Sciences, Metrum Research Group and Clovis Oncology.See details»
EQT Life Sciences Co-Leads USD 135 Million Series B Financing in …
Jun 11, 2025 SpliceBio’s platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein, Protein Splicing, and protein …See details»
SpliceBio - Overview, News & Similar companies | ZoomInfo.com
View SpliceBio (splice.bio) location in Catalonia, Spain , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
SpliceBio SL - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 For additional information, please visit www.splice.bio . About SB-007 SB-007 is an investigational Protein Splicing dual AAV gene therapy in development for the treatment of …See details»
SpliceBio (Spain) Funding: $193.9M
Jul 7, 2025 Spain | Funding: $193.9M (+) Website: https://splice.bio/ Splice Bio is a biotech company developing gene therapies based on a platform that …See details»
SpliceBio Nabs $135 Million Series B To Advance …
Jun 11, 2025 The company’s intein-based technology is initially aimed at Stargardt disease, a type of macular degeneration. Barcelona-based genetic …See details»
SpliceBio gathers $135m for eye disease gene therapies
1 day ago Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.See details»
Miquel Vila-Perelló - Phacilitate 2025
Dr. Miquel Vila-Perelló is the co-founder and Chief Executive Officer of SpliceBio, a genetic medicines company he has led since its inception in 2014 (formerly ProteoDesign). Under his …See details»
Spain’s SpliceBio Secures $135M Series B to Advance AAV Gene …
BARCELONA, SPAIN, 11 June 2025- SpliceBio, a Spanish biotech company, has successfully closed a $135 million Series B funding round, with significant backing from pharmaceutical …See details»
Splice Bio - Funding, Financials, Valuation & Investors
Splice Bio is funded by 10 investors. EQT Life Sciences and New Enterprise Associates are the most recent investors. Which investors participated in the most funding rounds?See details»
SpliceBio breaks gene therapy packaging barriers with US$135 …
SpliceBio has secured US$135 million in Series B funding to tackle one of gene therapy’s most persistent technical barriers: the packaging capacity limitations that have rendered many …See details»
Roche builds gene therapy portfolio with SpliceBio deal
1 day ago Roche’s gene therapy unit Spark has added to its pipeline in inherited retinal diseases (IRDs) with a $216 million alliance with Spanish biotech SpliceBio. Under the terms of the …See details»
What I Read This Week: SpliceBio and the Quest to Overcome …
Jun 18, 2025 What’s the big deal about Splice Bio? SpliceBio, a biotech company developing treatments for diseases caused by large gene mutations, has raised $135 million in Series B …See details»
SpliceBio gets $135M shortly after starting first clinical trial
Jun 11, 2025 In the difficult field of gene therapies, some biotech startups are still reeling in large amounts of capital. Barcelona-based SpliceBio is the latest. The 40 …See details»
Series B - Splice Bio - 2025-06-11 - Crunchbase
Jun 11, 2025 Overview Organization Name Splice Bio Announced Date Jun 11, 2025 Funding Type Series B Funding Stage Early Stage Venture Money Raised obfuscatedSee details»
Splice Bio - Tech Details - Crunchbase
Highlights Splice Bio is actively using 7 technologies for its website, according to BuiltWith. These include SPF, Google Maps, and Microsoft Exchange Online.The intellectual property of Splice …See details»